Moderna, Inc. (MRNA) Net margin 2016–2025
Moderna, Inc. (MRNA) net profit margin by fiscal year — reported net income divided by reported revenue.
-145.2%FY2025 · since FY2016: -199.5% → -145.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -145.2% | -35.1 pp |
| FY2024 | -110.0% | -41.2 pp |
| FY2023 | -68.8% | -112.2 pp |
| FY2022 | 43.4% | -22.7 pp |
| FY2021 | 66.1% | +159.1 pp |
| FY2020 | -93.0% | +760.7 pp |
| FY2019 | -853.7% | -568.8 pp |
| FY2018 | -284.8% | -160.5 pp |
| FY2017 | -124.3% | +75.1 pp |
| FY2016 | -199.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice